OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...

Apollo Hospitals Chennai launches a Centre of Excellence for Parkinson’s Disease, offering advanced, personalized treatment ...

By adding new filters at water treatment plants, PolyGone is removing microplastics from the water system—and then recycling ...

The rise of advanced maternal age IVF is empowered by BaseCare Medical AI Undisturbed Culture for assisted reproduction.

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Explore how innovative sanitation projects in eThekwini are transforming communities, showcasing the Aquonic wastewater ...

The FDA has given accelerated approval to Bayer for oral HER2 tyrosine kinase inhibitor sevabertinib as a second-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), allowing it ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Backed by the Gauteng department of health, Steve Biko Academic Hospital has become a national hub for medical innovation ...

In a field where surgical credentials can vary widely, Dr. Michael A. Brusco: Northern Virginia’s World College of Refractive Surgery Fellow | Elite LASIK Surgeon Credentials introduces new clarity to ...

Bengaluru-based Waste is Gold Technologies has accumulated over 300 projects in seven years while remaining completely ...

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative ...